Recommended Products
Assay
97%
form
solid
mp
183-186 °C (lit.)
solubility
acetic acid: soluble 50 mg/mL, clear, colorless to faintly yellow
functional group
chloro
SMILES string
Cc1cc(Cl)nc(N)n1
InChI
1S/C5H6ClN3/c1-3-2-4(6)9-5(7)8-3/h2H,1H3,(H2,7,8,9)
InChI key
NPTGVVKPLWFPPX-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
2-Amino-4-chloro-6-methylpyrimidine is a nitification inhibitor.
Application
2-Amino-4-chloro-6-methylpyrimidine was used to study the influence of chlorine substitution in pyrimidine ring on proton donor ability of amino group in 2-aminopyrimidine.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Effects of nitrification inhibitors on denitrification of nitrate in soil.
Biology and Fertility of Soils, 2(4), 173-179 (1986)
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 97, 811-824 (2012-08-21)
The solid phase FTIR and FT-Raman spectra of 2-amino-4-chloro-6-methylpyrimidine (2A4Cl6MP) have been recorded in the regions 400-4000 and 50-4,000 cm(-1), respectively. The spectra have been interpreted interms of fundamentals modes, combination and overtone bands. The structure of the molecule has
Influence of chlorine-substitution in pyrimidine ring on proton donor ability in H-bond and parameters of amino group of 2-amino pyrimidine.
Vibrational Spectroscopy, 37(1), 97-109 (2005)
Biochemistry, 26(7), 1969-1973 (1987-04-07)
Thiaminase I from Bacillus thiaminolyticus strain Matsukawa et Misawa is completely and irreversibly inhibited by treatment with 4-amino-6-chloro-2-methylpyrimidine. Inhibition is a time-dependent first-order process, exhibiting a half-time of 4 h at an inhibitor concentration of 5 mM. A specific active-site-directed
Pharmaceutics, 3(3), 601-614 (2011-01-01)
In the pharmaceutical industry, co-crystals are becoming increasingly valuable as crystalline solids that can offer altered/improved physical properties of an active pharmaceutical ingredient (API) without changing its chemical identity or biological activity. In order to identify new solid forms of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service